Related Experiment Video
Updated: Jul 10, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
Osteoblast-specific deletion of Hrpt2/Cdc73 results in high bone mass and increased bone turnover
Casey J Droscha1, Cassandra R Diegel1, Nicole J Ethen1
1Program for Skeletal Disease and Tumor Microenvironment, Grand Rapids, MI, USA; Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, MI, USA.
Abstract:
Inactivating mutations that lead to loss of heterozygosity within the HRPT2/Cdc73 gene are directly linked to the development of primary hyperparathyroidism, parathyroid adenomas, and ossifying fibromas of the jaw (HPT-JT). The protein product of the Cdc73 gene, parafibromin, is a core member of the polymerase-associated factors (PAF) complex, which coordinates epigenetic modifiers and transcriptional machinery to control gene expression. We conditionally deleted Cdc73 within mesenchymal progenitors or within mature osteoblasts and osteocytes to determine the consequences of parafibromin loss within the mesenchymal lineage. Homozygous deletion of Cdc73 via the Dermo1-Cre driver resulted in embryos which lacked mesenchymal organ development of internal organs, including the heart and fetal liver. Immunohistochemical detection of cleaved caspase-3 revealed extensive apoptosis within the progenitor pools of developing organs. Unexpectedly, when Cdc73 was homozygously deleted within mature osteoblasts and osteocytes (via the Ocn-Cre driver), the mice had a normal life span but increased cortical and trabecular bone. OCN-Cre;Cdc73flox/flox bones displayed large cortical pores actively undergoing bone remodeling. Additionally the cortical bone of OCN-Cre;Cdc73flox/flox femurs contained osteocytes with marked amounts of cytoplasmic RNA and a high rate of apoptosis. Transcriptional analysis via RNA-seq within OCN-Cre;Cdc73flox/flox osteoblasts showed that loss of Cdc73 led to a derepression of osteoblast-specific genes, specifically those for collagen and other bone matrix proteins. These results aid in our understanding of the role parafibromin plays within transcriptional regulation, terminal differentiation, and bone homeostasis.
Insights
Loss of the Cdc73 gene (parafibromin) in mature bone cells disrupts gene expression, leading to increased bone mass and remodeling. This impacts transcriptional regulation and bone homeostasis.
Area of Science:
- Genetics and Molecular Biology
- Skeletal Biology and Bone Physiology
- Epigenetics and Transcriptional Regulation
Background:
- Inactivating mutations in the HRPT2/Cdc73 gene are linked to hyperparathyroidism and jaw ossifying fibromas (HPT-JT).
- Parafibromin, the protein product of Cdc73, is a key component of the polymerase-associated factors (PAF) complex, regulating gene expression through epigenetic mechanisms.
Purpose of the Study:
- To investigate the role of parafibromin in the mesenchymal lineage by conditionally deleting the Cdc73 gene.
- To determine the consequences of parafibromin loss in mature osteoblasts and osteocytes on bone development and homeostasis.
Main Methods:
- Conditional knockout mouse models using Dermo1-Cre and Ocn-Cre drivers to delete Cdc73 in specific cell populations.
- Immunohistochemistry for cleaved caspase-3 to assess apoptosis.
- RNA sequencing (RNA-seq) to analyze gene expression changes in osteoblasts.
- Micro-computed tomography (micro-CT) and histological analysis of bone structure.
Main Results:
- Homozygous deletion of Cdc73 in mesenchymal progenitors (Dermo1-Cre) led to embryonic lethality due to failed organ development and increased apoptosis.
- Conditional deletion of Cdc73 in mature osteoblasts/osteocytes (Ocn-Cre) resulted in mice with normal lifespan but significantly increased cortical and trabecular bone.
- OCN-Cre;Cdc73flox/flox bones showed enlarged cortical pores, active remodeling, osteocytes with high cytoplasmic RNA levels, and elevated apoptosis.
- RNA-seq revealed derepression of osteoblast-specific genes, including collagen and bone matrix proteins, in OCN-Cre;Cdc73flox/flox osteoblasts.
Conclusions:
- Parafibromin loss in mesenchymal progenitors is essential for embryonic organ development.
- Parafibromin plays a critical role in regulating transcriptional programs in mature osteoblasts, influencing terminal differentiation and bone matrix production.
- Loss of parafibromin in osteoblasts leads to altered bone remodeling and homeostasis, suggesting its involvement in maintaining skeletal integrity.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
Bone Remodeling and Repair

